• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 5. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidine carboxylic acids

Recent Advances in the Study of Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate (CAS: 102389-88-8)

Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate (CAS: 102389-88-8) is a chiral pyrrolidine derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including potential therapeutics for neurological disorders, infectious diseases, and cancer. Recent studies have explored its synthetic utility, pharmacological properties, and mechanistic insights, making it a focal point in contemporary research.

One of the most notable advancements in the study of this compound is its role in the synthesis of novel γ-aminobutyric acid (GABA) analogs. Researchers have demonstrated that Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate can be efficiently transformed into GABAergic ligands, which exhibit promising activity in modulating neurotransmitter receptors. These findings are particularly relevant for the development of treatments for epilepsy, anxiety, and other central nervous system disorders. The compound's chiral centers also allow for the exploration of stereoselective interactions with biological targets, enhancing its potential as a scaffold for drug design.

In addition to its neurological applications, recent studies have highlighted the compound's utility in antimicrobial research. A 2023 publication in the Journal of Medicinal Chemistry reported the synthesis of pyrrolidine-based antimicrobial agents derived from Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate. These agents exhibited potent activity against multidrug-resistant bacterial strains, underscoring the compound's potential in addressing the global antibiotic resistance crisis. The study also provided mechanistic insights into the compound's interaction with bacterial cell walls, offering a foundation for further optimization.

Another area of active research involves the use of this compound in cancer therapeutics. A team of researchers recently utilized Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate as a precursor for the synthesis of small-molecule inhibitors targeting specific oncogenic pathways. Preliminary in vitro and in vivo studies have shown that these inhibitors effectively suppress tumor growth with minimal off-target effects. The compound's ability to serve as a versatile building block for diverse pharmacophores has been a key factor in these advancements.

From a synthetic chemistry perspective, recent efforts have focused on optimizing the production and purification of Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate. Innovations in catalytic asymmetric synthesis have enabled the production of enantiomerically pure forms of the compound, which are critical for its application in chiral drug development. These methodological improvements not only enhance yield and purity but also align with the growing emphasis on sustainable and green chemistry practices in the pharmaceutical industry.

In conclusion, Dimethyl trans-(+/-)-pyrrolidine-3,4-dicarboxylate (CAS: 102389-88-8) continues to be a molecule of significant interest in chemical biology and medicinal chemistry. Its multifaceted applications in drug discovery, coupled with recent advancements in synthetic methodologies and mechanistic understanding, position it as a valuable tool for researchers. Future studies are expected to further explore its potential in addressing unmet medical needs, particularly in the realms of neurology, infectious diseases, and oncology.

• 498-95-3(piperidine-3-carboxylic acid)
• 94-60-0(Dimethyl Cyclohexane-1,4-dicarboxylate(1,4-Cyclohexanedicarboxylic Dimethyl Ester))
• 711-01-3(1-Adamantanecarboxylic Acid Methyl Ester)
• 868-57-5(DL-2-Methylbutyric Acid Methyl Ester)
• 1126-09-6(Ethyl piperidine-4-carboxylate)
• 667-83-4(Pantothenyl ethyl ether)
• 701-54-2(4-(Aminomethyl)cyclohexanecarboxylic Acid)
• 667-84-5(DL-Ethyl-panthenol)
• 1197-18-8(Tranexamic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)